Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases
Open Access
- 20 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cellular & Molecular Immunology
- Vol. 18 (6), 1528-1544
- https://doi.org/10.1038/s41423-020-0381-3
Abstract
Excessive release of neutrophil extracellular traps (NETs) is associated with disease severity and contributes to tissue injury, followed by severe organ damage. Pharmacological or genetic inhibition of NET release reduces pathology in multiple inflammatory disease models, indicating that NETs are potential therapeutic targets. Here, we demonstrate using a preclinical basket approach that our therapeutic anti-citrullinated protein antibody (tACPA) has broad therapeutic potential. Treatment with tACPA prevents disease symptoms in various mouse models with plausible NET-mediated pathology, including inflammatory arthritis (IA), pulmonary fibrosis, inflammatory bowel disease and sepsis. We show that citrulline residues in the N-termini of histones 2A and 4 are specific targets for therapeutic intervention, whereas antibodies against other N-terminal post-translational histone modifications have no therapeutic effects. Because citrullinated histones are generated during NET release, we investigated the ability of tACPA to inhibit NET formation. tACPA suppressed NET release from human neutrophils triggered with physiologically relevant human disease-related stimuli. Moreover, tACPA diminished NET release and potentially initiated NET uptake by macrophages in vivo, which was associated with reduced tissue damage in the joints of a chronic arthritis mouse model of IA. To our knowledge, we are the first to describe an antibody with NET-inhibiting properties and thereby propose tACPA as a drug candidate for NET-mediated inflammatory diseases, as it eliminates the noxious triggers that lead to continued inflammation and tissue damage in a multidimensional manner.Keywords
This publication has 92 references indexed in Scilit:
- Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in miceProceedings of the National Academy of Sciences of the United States of America, 2013
- Neutrophils in the pathogenesis and manifestations of SLENature Reviews Rheumatology, 2011
- Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitorAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular trapsThe Journal of Experimental Medicine, 2010
- Extracellular histones are major mediators of death in sepsisNature Medicine, 2009
- Netting neutrophils in autoimmune small-vessel vasculitisNature Medicine, 2009
- Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritisThe Journal of Experimental Medicine, 2009
- Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formationThe Journal of cell biology, 2009
- Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic miceThe Journal of Experimental Medicine, 2008
- Neutrophil Extracellular Traps Kill BacteriaScience, 2004